Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 249


Reply to Trewavas et al. and Calvo and Trewavas.

Taiz L, Alkon D, Draguhn A, Murphy A, Blatt M, Thiel G, Robinson DG.

Trends Plant Sci. 2020 Mar;25(3):218-220. doi: 10.1016/j.tplants.2019.12.020. Epub 2020 Jan 8. No abstract available.


Focused Ethnographic Examination of Barriers to Use of Long-Acting Injectable Antipsychotics.

Robinson DG, Subramaniam A, Fearis PJ, Shi R, Walsh M, Hanna LA, Kane JM.

Psychiatr Serv. 2019 Dec 18:appips201900236. doi: 10.1176/ [Epub ahead of print]


Striatal volume and functional connectivity correlate with weight gain in early-phase psychosis.

Homan P, Argyelan M, Fales CL, Barber AD, DeRosse P, Szeszko PR, Robinson DG, Lencz T, Malhotra AK.

Neuropsychopharmacology. 2019 Oct;44(11):1948-1954. doi: 10.1038/s41386-019-0464-y. Epub 2019 Jul 17.


Plants Neither Possess nor Require Consciousness.

Taiz L, Alkon D, Draguhn A, Murphy A, Blatt M, Hawes C, Thiel G, Robinson DG.

Trends Plant Sci. 2019 Aug;24(8):677-687. doi: 10.1016/j.tplants.2019.05.008. Epub 2019 Jul 3. Review.


The functional false discovery rate with applications to genomics.

Chen X, Robinson DG, Storey JD.

Biostatistics. 2019 May 28. pii: kxz010. doi: 10.1093/biostatistics/kxz010. [Epub ahead of print]


Predictors of Hospitalization of Individuals With First-Episode Psychosis: Data From a 2-Year Follow-Up of the RAISE-ETP.

Robinson DG, Schooler NR, Rosenheck RA, Lin H, Sint KJ, Marcy P, Kane JM.

Psychiatr Serv. 2019 Jul 1;70(7):569-577. doi: 10.1176/ Epub 2019 May 14.


Patients With Early-Phase Schizophrenia Will Accept Treatment With Sustained-Release Medication (Long-Acting Injectable Antipsychotics): Results From the Recruitment Phase of the PRELAPSE Trial.

Kane JM, Schooler NR, Marcy P, Achtyes ED, Correll CU, Robinson DG.

J Clin Psychiatry. 2019 Apr 23;80(3). pii: 18m12546. doi: 10.4088/JCP.18m12546.


An Evaluation of a Battery of Functional and Structural Tests as Predictors of Likely Risk of Progression of Age-Related Macular Degeneration.

Robinson DG, Margrain TH, Bailey C, Binns AM.

Invest Ophthalmol Vis Sci. 2019 Feb 1;60(2):580-589. doi: 10.1167/iovs.18-25092.


Structural similarity networks predict clinical outcome in early-phase psychosis.

Homan P, Argyelan M, DeRosse P, Szeszko PR, Gallego JA, Hanna L, Robinson DG, Kane JM, Lencz T, Malhotra AK.

Neuropsychopharmacology. 2019 Apr;44(5):915-922. doi: 10.1038/s41386-019-0322-y. Epub 2019 Jan 24.


Off-hours use of a smartphone intervention to extend support for individuals with schizophrenia spectrum disorders recently discharged from a psychiatric hospital.

Achtyes ED, Ben-Zeev D, Luo Z, Mayle H, Burke B, Rotondi AJ, Gottlieb JD, Brunette MF, Mueser KT, Gingerich S, Meyer-Kalos PS, Marcy P, Schooler NR, Robinson DG, Kane JM.

Schizophr Res. 2019 Apr;206:200-208. doi: 10.1016/j.schres.2018.11.026. Epub 2018 Dec 11.


Alternative polyadenylation factors link cell cycle to migration.

Mitra M, Johnson EL, Swamy VS, Nersesian LE, Corney DC, Robinson DG, Taylor DG, Ambrus AM, Jelinek D, Wang W, Batista SL, Coller HA.

Genome Biol. 2018 Oct 25;19(1):176. doi: 10.1186/s13059-018-1551-9.


A potential role for adjunctive omega-3 polyunsaturated fatty acids for depression and anxiety symptoms in recent onset psychosis: Results from a 16 week randomized placebo-controlled trial for participants concurrently treated with risperidone.

Robinson DG, Gallego JA, John M, Hanna LA, Zhang JP, Birnbaum ML, Greenberg J, Naraine M, Peters BD, McNamara RK, Malhotra AK, Szeszko PR.

Schizophr Res. 2019 Feb;204:295-303. doi: 10.1016/j.schres.2018.09.006. Epub 2018 Sep 19.


Low-Level Nighttime Light Therapy for Age-Related Macular Degeneration: A Randomized Clinical Trial.

Robinson DG, Margrain TH, Dunn MJ, Bailey C, Binns AM.

Invest Ophthalmol Vis Sci. 2018 Sep 4;59(11):4531-4541. doi: 10.1167/iovs.18-24284.


Frequency specific resting state functional abnormalities in psychosis.

Gohel S, Gallego JA, Robinson DG, DeRosse P, Biswal B, Szeszko PR.

Hum Brain Mapp. 2018 Nov;39(11):4509-4518. doi: 10.1002/hbm.24302. Epub 2018 Aug 30.


Implementation and fidelity assessment of the NAVIGATE treatment program for first episode psychosis in a multi-site study.

Mueser KT, Meyer-Kalos PS, Glynn SM, Lynde DW, Robinson DG, Gingerich S, Penn DL, Cather C, Gottlieb JD, Marcy P, Wiseman JL, Potretzke S, Brunette MF, Schooler NR, Addington J, Rosenheck RA, Estroff SE, Kane JM.

Schizophr Res. 2019 Feb;204:271-281. doi: 10.1016/j.schres.2018.08.015. Epub 2018 Aug 20.


Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Meta-regression.

Correll CU, Galling B, Pawar A, Krivko A, Bonetto C, Ruggeri M, Craig TJ, Nordentoft M, Srihari VH, Guloksuz S, Hui CLM, Chen EYH, Valencia M, Juarez F, Robinson DG, Schooler NR, Brunette MF, Mueser KT, Rosenheck RA, Marcy P, Addington J, Estroff SE, Robinson J, Penn D, Severe JB, Kane JM.

JAMA Psychiatry. 2018 Jun 1;75(6):555-565. doi: 10.1001/jamapsychiatry.2018.0623.


Frontal lobe functioning during a simple response conflict task in first-episode psychosis and its relationship to treatment response.

Shafritz KM, Ikuta T, Greene A, Robinson DG, Gallego J, Lencz T, DeRosse P, Kingsley PB, Szeszko PR.

Brain Imaging Behav. 2019 Apr;13(2):541-553. doi: 10.1007/s11682-018-9876-2.


Turnover of Tonoplast Proteins.

Ivanov R, Robinson DG.

Plant Physiol. 2018 May;177(1):10-11. doi: 10.1104/pp.18.00322. No abstract available.


Auxin and Vesicle Traffic.

Robinson DG, Hawes C, Hillmer S, Jürgens G, Schwechheimer C, Stierhof YD, Viotti C.

Plant Physiol. 2018 Mar;176(3):1884-1888. doi: 10.1104/pp.17.01510. Epub 2018 Mar 6. No abstract available.


Retromer and VSR Recycling: A Red Herring?

Robinson DG.

Plant Physiol. 2018 Jan;176(1):483-484. doi: 10.1104/pp.17.01502. No abstract available.


Investigation of superior longitudinal fasciculus fiber complexity in recent onset psychosis.

Szeszko PR, Tan ET, Uluğ AM, Kingsley PB, Gallego JA, Rhindress K, Malhotra AK, Robinson DG, Marinelli L.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Feb 2;81:114-121. doi: 10.1016/j.pnpbp.2017.10.019. Epub 2017 Oct 28.


Psychopharmacological Treatment in the RAISE-ETP Study: Outcomes of a Manual and Computer Decision Support System Based Intervention.

Robinson DG, Schooler NR, Correll CU, John M, Kurian BT, Marcy P, Miller AL, Pipes R, Trivedi MH, Kane JM.

Am J Psychiatry. 2018 Feb 1;175(2):169-179. doi: 10.1176/appi.ajp.2017.16080919. Epub 2017 Sep 15.


Accounting for group differences in study retention in a randomized trial of specialized treatment for first episode psychosis.

Sint K, Rosenheck R, Robinson DG, Schooler NR, Marcy P, Kane JM, Mueser KT, Lin H; other RAISE ETP Investigators.

Schizophr Res. 2018 May;195:481-487. doi: 10.1016/j.schres.2017.08.029. Epub 2017 Aug 25.


Demographic, psychosocial, clinical, and neurocognitive baseline characteristics of Black Americans in the RAISE-ETP study.

Nagendra A, Schooler NR, Kane JM, Robinson DG, Mueser KT, Estroff SE, Addington J, Marcy P, Penn DL.

Schizophr Res. 2018 Mar;193:64-68. doi: 10.1016/j.schres.2017.06.038. Epub 2017 Jul 11.


Demographic and clinical correlates of substance use disorders in first episode psychosis.

Brunette MF, Mueser KT, Babbin S, Meyer-Kalos P, Rosenheck R, Correll CU, Cather C, Robinson DG, Schooler NR, Penn DL, Addington J, Estroff SE, Gottlieb J, Glynn SM, Marcy P, Robinson J, Kane JM.

Schizophr Res. 2018 Apr;194:4-12. doi: 10.1016/j.schres.2017.06.039. Epub 2017 Jul 8.


Perceived Autonomy Support in the NIMH RAISE Early Treatment Program.

Browne J, Penn DL, Bauer DJ, Meyer-Kalos P, Mueser KT, Robinson DG, Addington J, Schooler NR, Glynn SM, Gingerich S, Marcy P, Kane JM.

Psychiatr Serv. 2017 Sep 1;68(9):916-922. doi: 10.1176/ Epub 2017 Jun 1.


Incomes and Outcomes: Social Security Disability Benefits in First-Episode Psychosis.

Rosenheck RA, Estroff SE, Sint K, Lin H, Mueser KT, Robinson DG, Schooler NR, Marcy P, Kane JM; RAISE-ETP Investigators.

Am J Psychiatry. 2017 Sep 1;174(9):886-894. doi: 10.1176/appi.ajp.2017.16111273. Epub 2017 Apr 21.


Greater extracellular free-water in first-episode psychosis predicts better neurocognitive functioning.

Lyall AE, Pasternak O, Robinson DG, Newell D, Trampush JW, Gallego JA, Fava M, Malhotra AK, Karlsgodt KH, Kubicki M, Szeszko PR.

Mol Psychiatry. 2018 Mar;23(3):701-707. doi: 10.1038/mp.2017.43. Epub 2017 Mar 28.


Relationship between Duration of Untreated Psychosis and Intrinsic Corticostriatal Connectivity in Patients with Early Phase Schizophrenia.

Sarpal DK, Robinson DG, Fales C, Lencz T, Argyelan M, Karlsgodt KH, Gallego JA, John M, Kane JM, Szeszko PR, Malhotra AK.

Neuropsychopharmacology. 2017 Oct;42(11):2214-2221. doi: 10.1038/npp.2017.55. Epub 2017 Mar 15.


Hippocampal subregion volume changes associated with antipsychotic treatment in first-episode psychosis.

Rhindress K, Robinson DG, Gallego JA, Wellington R, Malhotra AK, Szeszko PR.

Psychol Med. 2017 Jul;47(10):1706-1718. doi: 10.1017/S0033291717000137. Epub 2017 Feb 14.


Widespread changes in mRNA stability contribute to quiescence-specific gene expression patterns in a fibroblast model of quiescence.

Johnson EL, Robinson DG, Coller HA.

BMC Genomics. 2017 Feb 1;18(1):123. doi: 10.1186/s12864-017-3521-0.


Trauma advanced practice provider programme development in an academic setting to optimize care coordination.

Woodfall MC, Browder TD, Alfaro JM, Claudius MA, Chan GK, Robinson DG, Spain DA.

Trauma Surg Acute Care Open. 2017 Jan 27;2(1):e000068. doi: 10.1136/tsaco-2016-000068. eCollection 2017.


Psychological well-being and mental health recovery in the NIMH RAISE early treatment program.

Browne J, Penn DL, Meyer-Kalos PS, Mueser KT, Estroff SE, Brunette MF, Correll CU, Robinson J, Rosenheck RA, Schooler N, Robinson DG, Addington J, Marcy P, Kane JM.

Schizophr Res. 2017 Jul;185:167-172. doi: 10.1016/j.schres.2016.11.032. Epub 2016 Nov 29.


Supported employment and education in comprehensive, integrated care for first episode psychosis: Effects on work, school, and disability income.

Rosenheck R, Mueser KT, Sint K, Lin H, Lynde DW, Glynn SM, Robinson DG, Schooler NR, Marcy P, Mohamed S, Kane JM.

Schizophr Res. 2017 Apr;182:120-128. doi: 10.1016/j.schres.2016.09.024. Epub 2016 Sep 23.


mHealth for Schizophrenia: Patient Engagement With a Mobile Phone Intervention Following Hospital Discharge.

Ben-Zeev D, Scherer EA, Gottlieb JD, Rotondi AJ, Brunette MF, Achtyes ED, Mueser KT, Gingerich S, Brenner CJ, Begale M, Mohr DC, Schooler N, Marcy P, Robinson DG, Kane JM.

JMIR Ment Health. 2016 Jul 27;3(3):e34. doi: 10.2196/mental.6348.


Receptor-mediated sorting of soluble vacuolar proteins: myths, facts, and a new model.

Robinson DG, Neuhaus JM.

J Exp Bot. 2016 Aug;67(15):4435-49. doi: 10.1093/jxb/erw222. Epub 2016 Jun 4. Review.


Health Technology Intervention After Hospitalization for Schizophrenia: Service Utilization and User Satisfaction.

Baumel A, Correll CU, Hauser M, Brunette M, Rotondi A, Ben-Zeev D, Gottlieb JD, Mueser KT, Achtyes ED, Schooler NR, Robinson DG, Gingerich S, Marcy P, Meyer-Kalos P, Kane JM.

Psychiatr Serv. 2016 Sep 1;67(9):1035-8. doi: 10.1176/ Epub 2016 Jun 1.


Early Mortality Among People With Schizophrenia.

Robinson DG.

Am J Psychiatry. 2016 Jun 1;173(6):554-5. doi: 10.1176/appi.ajp.2016.16030334. No abstract available.


Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis.

Zhang JP, Lencz T, Zhang RX, Nitta M, Maayan L, John M, Robinson DG, Fleischhacker WW, Kahn RS, Ophoff RA, Kane JM, Malhotra AK, Correll CU.

Schizophr Bull. 2016 Nov;42(6):1418-1437. doi: 10.1093/schbul/sbw058. Epub 2016 May 23. Review.


Yes, We Have an Inflation of Reviews: But of the Wrong Kind!

Robinson DG.

Front Plant Sci. 2016 Apr 26;7:494. doi: 10.3389/fpls.2016.00494. eCollection 2016. No abstract available.


Response to Amos: Addressing Purported Methodological Flaws in RAISE-ETP Results.

Kane JM, Robinson DG, Schooler NR, Lin H, Rosenheck RA, Heinssen RK; RAISE-ETP Study Group.

Am J Psychiatry. 2016 May 1;173(5):535-6. doi: 10.1176/appi.ajp.2016.15111427r. No abstract available.


Age and Sex Effects on White Matter Tracts in Psychosis from Adolescence through Middle Adulthood.

Schwehm A, Robinson DG, Gallego JA, Karlsgodt KH, Ikuta T, Peters BD, Malhotra AK, Szeszko PR.

Neuropsychopharmacology. 2016 Sep;41(10):2473-80. doi: 10.1038/npp.2016.47. Epub 2016 Apr 12.


The identification of novel genetic variants associated with antipsychotic treatment response outcomes in first-episode schizophrenia patients.

Drögemöller BI, Emsley R, Chiliza B, van der Merwe L, Wright GE, Daya M, Hoal E, Malhotra AK, Lencz T, Robinson DG, Zhang JP, Asmal L, Niehaus DJ, Warnich L.

Pharmacogenet Genomics. 2016 May;26(5):235-42. doi: 10.1097/FPC.0000000000000213.


Cost-Effectiveness of Comprehensive, Integrated Care for First Episode Psychosis in the NIMH RAISE Early Treatment Program.

Rosenheck R, Leslie D, Sint K, Lin H, Robinson DG, Schooler NR, Mueser KT, Penn DL, Addington J, Brunette MF, Correll CU, Estroff SE, Marcy P, Robinson J, Severe J, Rupp A, Schoenbaum M, Kane JM.

Schizophr Bull. 2016 Jul;42(4):896-906. doi: 10.1093/schbul/sbv224. Epub 2016 Jan 31.


Coordinated Technology-Delivered Treatment to Prevent Rehospitalization in Schizophrenia: A Novel Model of Care.

Brunette MF, Rotondi AJ, Ben-Zeev D, Gottlieb JD, Mueser KT, Robinson DG, Achtyes ED, Gingerich S, Marcy P, Schooler NR, Meyer-Kalos P, Kane JM.

Psychiatr Serv. 2016 Apr 1;67(4):444-7. doi: 10.1176/ Epub 2016 Jan 4.


Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program.

Kane JM, Robinson DG, Schooler NR, Mueser KT, Penn DL, Rosenheck RA, Addington J, Brunette MF, Correll CU, Estroff SE, Marcy P, Robinson J, Meyer-Kalos PS, Gottlieb JD, Glynn SM, Lynde DW, Pipes R, Kurian BT, Miller AL, Azrin ST, Goldstein AB, Severe JB, Lin H, Sint KJ, John M, Heinssen RK.

Am J Psychiatry. 2016 Apr 1;173(4):362-72. doi: 10.1176/appi.ajp.2015.15050632. Epub 2015 Oct 20.


Unconventional protein secretion in plants: a critical assessment.

Robinson DG, Ding Y, Jiang L.

Protoplasma. 2016 Jan;253(1):31-43. doi: 10.1007/s00709-015-0887-1. Epub 2015 Sep 26. Review.


Relationship of Cognition to Clinical Response in First-Episode Schizophrenia Spectrum Disorders.

Trampush JW, Lencz T, DeRosse P, John M, Gallego JA, Petrides G, Hassoun Y, Zhang JP, Addington J, Kellner CH, Tohen M, Burdick KE, Goldberg TE, Kane JM, Robinson DG, Malhotra AK.

Schizophr Bull. 2015 Nov;41(6):1237-47. doi: 10.1093/schbul/sbv120. Epub 2015 Sep 25.


Exocyst-Positive Organelles and Autophagosomes Are Distinct Organelles in Plants.

Lin Y, Ding Y, Wang J, Shen J, Kung CH, Zhuang X, Cui Y, Yin Z, Xia Y, Lin H, Robinson DG, Jiang L.

Plant Physiol. 2015 Nov;169(3):1917-32. doi: 10.1104/pp.15.00953. Epub 2015 Sep 10.


A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes.

Robinson DG, Gallego JA, John M, Petrides G, Hassoun Y, Zhang JP, Lopez L, Braga RJ, Sevy SM, Addington J, Kellner CH, Tohen M, Naraine M, Bennett N, Greenberg J, Lencz T, Correll CU, Kane JM, Malhotra AK.

Schizophr Bull. 2015 Nov;41(6):1227-36. doi: 10.1093/schbul/sbv125. Epub 2015 Sep 3.

Supplemental Content

Loading ...
Support Center